SPOTLIGHT -
Agents in late-stage development for the treatment of asthma, COPD, and PAH
Boehringer Ingelheim to Cap Out-of-Pocket Cost for Inhalers at $35
Asthma Rescue Medication Airsupra is Now Available
Airsupra is an anti-inflammatory rescue medication that can treat the symptoms of asthma while helping to prevent an attack.
FDA Grants Priority Review for Sotatercept in Pulmonary Arterial Hypertension
Sotatercept is a first-in-class therapy to treat the rare disease pulmonary arterial hypertension. The FDA has assigned a target action date of March 26, 2024.
FDA Accepts sNDA for Ofev in Children with Rare Lung Disease
If approved, Ofev would be the first approved treatment for children and adolescents with fibrosing interstitial lung disease. A decision is expected in the fourth quarter of this year.
FDA Approves Tezspire in Pre-Filled Pen
Tezspire is a biologic that specifically targets the inflammation associated with asthma.
FDA Approves Rescue Combination Medication for Asthma
Airsupra is the first rescue medication to manage both the symptoms and the inflammation associated with asthma.